In conclusion, HAUS1 combined with immunotherapy achieved significative results and the high expression of HAUS1 promoted HCC tumorigenesis and development by regulating immune microenvironment, regulating cell cycle, inhibiting apoptosis and other ways, leading to poor prognosis, which may have important diagnostic, prognostic and therapeutic value. This evidence concerns the gene HAUS1 and hepatocellular carcinoma.